Stay updated on Dulaglutide Doses in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page.

Latest updates to the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe Manatí, Puerto Rico site entry was updated to a different spelling (“Manati” without the accent). The page footer/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3”.SummaryDifference0.1%

- Check19 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedThe site now lists revision v3.5.0 and no longer shows v3.4.3.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page. This appears to be a minor platform update with no changes to the study information.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded Revision: v3.4.2; removed the previous government funding lapse notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check92 days agoChange DetectedNotice about government funding lapse affecting site status and a version update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Dulaglutide Doses in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page.